MIRA Pharmaceuticals, Inc. (MIRA)
0.551
+0.01
(+2.00%)
USD |
NASDAQ |
Nov 06, 10:45
MIRA Pharmaceuticals Shareholders Equity (Quarterly) : 8.162M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.162M |
| March 31, 2026 | 9.349M |
| December 31, 2025 | 10.39M |
| September 30, 2025 | 7.549M |
| June 30, 2025 | 0.5699M |
| March 31, 2025 | 1.294M |
| December 31, 2024 | 2.200M |
| September 30, 2024 | 3.574M |
| June 30, 2024 | 2.219M |
| Date | Value |
|---|---|
| March 31, 2024 | 3.157M |
| December 31, 2023 | 4.374M |
| September 30, 2023 | 8.115M |
| June 30, 2023 | 1.197M |
| March 31, 2023 | -1.790M |
| December 31, 2022 | -0.5962M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | 2.505M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Resonate Blends, Inc. | -5.364M |
| Breakthrough Chemistry, Inc. | 0.8373M |
| Kaya Holdings, Inc. | -0.5474M |
| Cardiac Biotech Solutions, Inc. | -2.221M |
| Real Brands, Inc. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.203M |
| Total Liabilities (Quarterly) | 0.0408M |
| Current Ratio | 200.19 |